• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国乙肝病毒感染人群中肝细胞癌筛查率的十年变化。

A Decade-old Change in the Screening Rate for Hepatocellular Carcinoma Among a Hepatitis B Virus-infected Population in Korea.

作者信息

Kim Hee Yeon, Kim Chang Wook, Choi Jong Young, Park Chung-Hwa, Lee Chang Don, Yim Hyeon Woo

机构信息

Department of Internal Medicine, Division of Hepatology, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.

出版信息

Chin Med J (Engl). 2016 Jan 5;129(1):15-21. doi: 10.4103/0366-6999.172551.

DOI:10.4103/0366-6999.172551
PMID:26712427
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4797536/
Abstract

BACKGROUND

Evaluating a change in the screening rate for hepatocellular carcinoma (HCC) is critical for understanding screening implementation, and whether targeted population groups are receiving proper screening. This study examined recent nationwide changes in HCC screening use among hepatitis B virus (HBV)-infected populations after the introduction of the Korean National Cancer Screening Program and predictors of screening adherence.

METHODS

We analyzed 165 and 276 participants ≥40 years of age who were hepatitis B surface antigen-positive from 2001 (14,936 participants) to 2010-2011 (9159 participants) Korea National Health and Nutrition Examination Surveys, respectively. Demographic data, socioeconomic factors, and HCC screening use were collected by means of self-reported questionnaires.

RESULTS

The rate of HCC screening within the previous 2 years increased significantly from 17.5% in 2001 to 40.3% in 2010-2011 (P < 0.0001). The rate of HCC screening use increased from 2001 to 2010-2011 in all study populations. Subjects who had a higher income status and were aware of their infection were more likely to have undergone recent HCC screening.

CONCLUSIONS

This study showed a substantial increase in HCC screening in high-risk HBV-infected subjects from 2001 to 2010-2011. However, the HCC screening participation rate remained suboptimal despite the introduction of the nationwide screening program. Efforts should be made to identify high-risk individuals and increase attendance at HCC screening events among high-risk groups.

摘要

背景

评估肝细胞癌(HCC)筛查率的变化对于理解筛查实施情况以及目标人群是否接受了适当的筛查至关重要。本研究调查了韩国国家癌症筛查计划实施后,全国范围内乙肝病毒(HBV)感染人群中HCC筛查使用情况的近期变化以及筛查依从性的预测因素。

方法

我们分别分析了2001年(14936名参与者)至2010 - 2011年(9159名参与者)韩国国家健康与营养检查调查中年龄≥40岁的165名和276名乙肝表面抗原阳性参与者。通过自我报告问卷收集人口统计学数据、社会经济因素和HCC筛查使用情况。

结果

前两年内的HCC筛查率从2001年的17.5%显著增加到2010 - 2011年的40.3%(P < 0.0001)。在所有研究人群中,HCC筛查使用率从2001年到2010 - 2011年都有所增加。收入状况较高且知晓自身感染情况的受试者近期更有可能接受HCC筛查。

结论

本研究表明,2001年至2010 - 2011年期间,高危HBV感染受试者的HCC筛查率大幅上升。然而,尽管实施了全国性筛查计划,HCC筛查参与率仍未达到最佳水平。应努力识别高危个体,并提高高危人群参加HCC筛查活动的比例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b2/4797536/9fc63a0f3f9a/CMJ-129-15-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b2/4797536/9fc63a0f3f9a/CMJ-129-15-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b2/4797536/9fc63a0f3f9a/CMJ-129-15-g001.jpg

相似文献

1
A Decade-old Change in the Screening Rate for Hepatocellular Carcinoma Among a Hepatitis B Virus-infected Population in Korea.韩国乙肝病毒感染人群中肝细胞癌筛查率的十年变化。
Chin Med J (Engl). 2016 Jan 5;129(1):15-21. doi: 10.4103/0366-6999.172551.
2
Hepatocellular carcinoma screening in a hepatitis B virus-infected Korean population.在乙型肝炎病毒感染的韩国人群中进行肝细胞癌筛查。
Dig Dis Sci. 2012 Dec;57(12):3258-64. doi: 10.1007/s10620-012-2281-6. Epub 2012 Jun 23.
3
Factors associated with use of ultrasonography screening for hepatocellular carcinoma among hepatitis B or C carriers.与乙型肝炎或丙型肝炎病毒携带者使用超声检查筛查肝细胞癌相关的因素。
Cancer Epidemiol. 2010 Dec;34(6):713-6. doi: 10.1016/j.canep.2010.09.003. Epub 2010 Oct 13.
4
[The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].[抗-HBc及隐匿性乙型肝炎病毒感染在HBsAg和抗-HCV阴性酒精性肝硬化患者肝细胞癌发生中的意义]
Korean J Hepatol. 2008 Mar;14(1):67-76. doi: 10.3350/kjhep.2008.14.1.67.
5
Community-based screening for hepatocellular carcinoma in elderly residents in a hepatitis B- and C-endemic area.在乙型肝炎和丙型肝炎流行地区,对老年居民进行基于社区的肝细胞癌筛查。
J Gastroenterol Hepatol. 2011 Jan;26(1):129-34. doi: 10.1111/j.1440-1746.2010.06476.x.
6
Relative etiological role of prior hepatitis B virus infection and nonalcoholic fatty liver disease in the development of non-B non-C hepatocellular carcinoma in a hepatitis B-endemic area.在乙型肝炎高发地区,既往乙型肝炎病毒感染和非酒精性脂肪性肝病在非乙型肝炎非丙型肝炎相关性肝细胞癌发展中的相对病因学作用。
Digestion. 2011;84 Suppl 1:17-22. doi: 10.1159/000333210. Epub 2011 Dec 2.
7
High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.尼泊尔肝硬化或肝细胞癌患者中乙肝病毒感染及下腔静脉阻塞的高患病率。
J Gastroenterol Hepatol. 2007 Nov;22(11):1921-8. doi: 10.1111/j.1440-1746.2006.04611.x.
8
High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load.高水平的乙肝表面抗原会增加低 HBV 载量患者发生肝细胞癌的风险。
Gastroenterology. 2012 May;142(5):1140-1149.e3; quiz e13-4. doi: 10.1053/j.gastro.2012.02.007. Epub 2012 Feb 11.
9
Prospective study on the risk of hepatocellular carcinoma among hepatitis C virus-positive blood donors focusing on demographic factors, alanine aminotransferase level at donation and interaction with hepatitis B virus.关于丙型肝炎病毒阳性献血者肝细胞癌风险的前瞻性研究,重点关注人口统计学因素、献血时的丙氨酸转氨酶水平以及与乙型肝炎病毒的相互作用。
Int J Cancer. 2004 Dec 20;112(6):1075-80. doi: 10.1002/ijc.20507.
10
Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.乙型肝炎病毒相关性肝移植:适应证减少及趋势变化
World J Gastroenterol. 2015 Jul 14;21(26):8140-7. doi: 10.3748/wjg.v21.i26.8140.

引用本文的文献

1
Interventions to Improve Surveillance for Hepatocellular Carcinoma in High-Risk Patients: A Scoping Review.干预措施以提高高危患者肝癌监测:范围综述。
J Gastrointest Cancer. 2024 Mar;55(1):1-14. doi: 10.1007/s12029-023-00944-1. Epub 2023 Jun 16.
2
Patient-, Provider-, and System-Level Barriers to Surveillance for Hepatocellular Carcinoma in High-Risk Patients in the USA: a Scoping Review.美国高危人群肝癌监测的患者、提供者和系统层面障碍:范围综述。
J Gastrointest Cancer. 2023 Jun;54(2):332-356. doi: 10.1007/s12029-022-00851-x. Epub 2022 Jul 26.
3
Efficacy of Real-world Entecavir Therapy in Treatment-naïve Chronic Hepatitis B Patients.

本文引用的文献

1
Factors associated with compliance with recommendations for liver cancer screening in Korea: a nationwide survey in Korea.与韩国肝癌筛查建议遵循情况相关的因素:韩国全国范围的调查。
PLoS One. 2013 Jun 28;8(6):e68315. doi: 10.1371/journal.pone.0068315. Print 2013.
2
Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010.韩国癌症统计数据:2010 年的发病率、死亡率、生存率和流行率。
Cancer Res Treat. 2013 Mar;45(1):1-14. doi: 10.4143/crt.2013.45.1.1. Epub 2013 Mar 31.
3
Cancer screening status in Korea, 2011: results from the Korean National Cancer Screening Survey.
真实世界恩替卡韦治疗初治慢性乙型肝炎患者的疗效。
Chin Med J (Engl). 2017 Sep 20;130(18):2190-2197. doi: 10.4103/0366-6999.213969.
4
A Case Series of Liver Abscess Formation after Transcatheter Arterial Chemoembolization for Hepatic Tumors.肝肿瘤经动脉化疗栓塞术后肝脓肿形成的病例系列
Chin Med J (Engl). 2017 Jun 5;130(11):1314-1319. doi: 10.4103/0366-6999.206345.
5
Kinetics of Hepatitis B Surface Antigen Level in Chronic Hepatitis B Patients who Achieved Hepatitis B Surface Antigen Loss during Pegylated Interferon Alpha-2a Treatment.聚乙二醇化干扰素α-2a治疗期间实现乙肝表面抗原消失的慢性乙型肝炎患者的乙肝表面抗原水平动力学
Chin Med J (Engl). 2017 Mar 5;130(5):559-565. doi: 10.4103/0366-6999.200554.
6
Knockdown of Decoy Receptor 3 Impairs Growth and Invasiveness of Hepatocellular Carcinoma Cell Line of HepG2.诱饵受体3的敲低削弱了肝癌细胞系HepG2的生长和侵袭能力。
Chin Med J (Engl). 2016 Nov 5;129(21):2623-2629. doi: 10.4103/0366-6999.192775.
2011年韩国癌症筛查状况:韩国全国癌症筛查调查结果
Asian Pac J Cancer Prev. 2012;13(4):1187-91. doi: 10.7314/apjcp.2012.13.4.1187.
4
Hepatocellular carcinoma screening in a hepatitis B virus-infected Korean population.在乙型肝炎病毒感染的韩国人群中进行肝细胞癌筛查。
Dig Dis Sci. 2012 Dec;57(12):3258-64. doi: 10.1007/s10620-012-2281-6. Epub 2012 Jun 23.
5
Factors associated with attending the National Cancer Screening Program for liver cancer in Korea.韩国参加国家肝癌筛查项目的相关因素。
Asian Pac J Cancer Prev. 2012;13(2):731-6. doi: 10.7314/apjcp.2012.13.2.731.
6
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.欧洲肝脏研究学会-欧洲肿瘤内科学会临床实践指南:肝细胞癌的管理
J Hepatol. 2012 Apr;56(4):908-43. doi: 10.1016/j.jhep.2011.12.001.
7
Management of hepatocellular carcinoma: an update.肝细胞癌的管理:最新进展
Hepatology. 2011 Mar;53(3):1020-2. doi: 10.1002/hep.24199.
8
Global cancer statistics.全球癌症统计数据。
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90. doi: 10.3322/caac.20107. Epub 2011 Feb 4.
9
Liver cancer screening in Korea: a report on the 2008 National Cancer Screening Programme.韩国的肝癌筛查:2008年国家癌症筛查计划报告。
Asian Pac J Cancer Prev. 2010;11(5):1305-10.
10
Factors associated with use of ultrasonography screening for hepatocellular carcinoma among hepatitis B or C carriers.与乙型肝炎或丙型肝炎病毒携带者使用超声检查筛查肝细胞癌相关的因素。
Cancer Epidemiol. 2010 Dec;34(6):713-6. doi: 10.1016/j.canep.2010.09.003. Epub 2010 Oct 13.